Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DZLH13
|
|||
| Drug Name |
AdAPT-001
|
|||
| Synonyms |
AIM-001
Click to Show/Hide
|
|||
| Drug Type |
Oncolytic virus
|
|||
| Indication | Aggressive cancer [ICD-11: 2A00-2F9Z; ICD-10: R45.6; ICD-9: 140-229] | Phase 1/2 | [1] | |
| Company |
EpicentRx
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04673942) A Phase 1/2, First in Human, Study to Evaluate the Safety and Tolerability of AdAPT-001 in Subjects With Refractory Solid Tumors. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.